These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9103060)

  • 1. [The status of vaccinal prophylaxis against influenza today].
    Bichurina MA; Fridman EA
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (6):104-8. PubMed ID: 9103060
    [No Abstract]   [Full Text] [Related]  

  • 2. [New vaccines against influenza via inhalation].
    Domínguez A; Vidal J
    Aten Primaria; 1999 Oct; 24(6):313-5. PubMed ID: 10596220
    [No Abstract]   [Full Text] [Related]  

  • 3. [The results of state trials of inactivated influenza vaccines for children].
    Vasil'eva RI; Smirnova LA; Rudenko LG; Drinevskiĭ VP; Tsaritsina IM
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Mar; (3):49-54. PubMed ID: 2968738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Live attenuated and inactivated influenza vaccines: data from direct comparative studies].
    Kashirina OS; Vasil'ev IuM
    Zh Mikrobiol Epidemiol Immunobiol; 2014; (1):103-19. PubMed ID: 24738303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized Comparison of Immunogenicity and Safety of Quadrivalent Recombinant Versus Inactivated Influenza Vaccine in Healthy Adults 18-49 Years of Age.
    Dunkle LM; Izikson R; Patriarca PA; Goldenthal KL; Muse D; Cox MMJ
    J Infect Dis; 2017 Dec; 216(10):1219-1226. PubMed ID: 28968871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of inactivated vaccines against influenza].
    Fridman EA; Peradze TV
    Tr Inst Im Pastera; 1982; 58():84-94. PubMed ID: 6764983
    [No Abstract]   [Full Text] [Related]  

  • 7. Modern vaccines. Pneumococcus and influenza.
    Shann F
    Lancet; 1990 Apr; 335(8694):898-901. PubMed ID: 1969994
    [No Abstract]   [Full Text] [Related]  

  • 8. Inactivated influenza virus vaccines in children.
    Ruben FL
    Clin Infect Dis; 2004 Mar; 38(5):678-88. PubMed ID: 14986252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The evaluation of the epidemiological efficacy of 3-component inactivated influenza vaccines using an intranasal application method].
    Marinich IG; Iaroshevskaia IIu; Konareva AL; Lonskaia NI; Shadrin AS; Salmin LV
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):76-8. PubMed ID: 8079581
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50-64 years of age.
    Baxter R; Patriarca PA; Ensor K; Izikson R; Goldenthal KL; Cox MM
    Vaccine; 2011 Mar; 29(12):2272-8. PubMed ID: 21277410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, immunogenicity and infectivity of new live attenuated influenza vaccines.
    Isakova-Sivak I; Rudenko L
    Expert Rev Vaccines; 2015; 14(10):1313-29. PubMed ID: 26289975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60 years of age and older.
    Forrest BD; Steele AD; Hiemstra L; Rappaport R; Ambrose CS; Gruber WC
    Vaccine; 2011 May; 29(20):3633-9. PubMed ID: 21440036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The trivalent polymer-subunit influenza vaccine Grippol studied in a controlled epidemiological trial (1)].
    El'shina GA; Masalin IuM; Shervali VI; Gorbunov MA; Lonskaia NI; Agafonova LV; Khaitov RM; Nekrasov AV; Ivanova AS; Matrosovich MN; Puchkova NG
    Voen Med Zh; 1996 Aug; 317(8):57-60. PubMed ID: 9036650
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer.
    Carr S; Allison KJ; Van De Velde LA; Zhang K; English EY; Iverson A; Daw NC; Howard SC; Navid F; Rodriguez-Galindo C; Yang J; Adderson EE; McCullers JA; Flynn PM
    J Infect Dis; 2011 Nov; 204(10):1475-82. PubMed ID: 21949042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Unresolved problems in the specific prevention of influenza].
    Fridman EA; Peradze TV
    Tr Inst Im Pastera; 1982; 59():6-12. PubMed ID: 7187568
    [No Abstract]   [Full Text] [Related]  

  • 16. [The immunization of elderly people against influenza].
    Bektimirov TA
    Vopr Virusol; 1993; 38(6):242-5. PubMed ID: 8303881
    [No Abstract]   [Full Text] [Related]  

  • 17. [Vaccinal prevention of influenza in children].
    Zykov MP; Vasil'eva RI
    Tr Inst Im Pastera; 1982; 58():30-8. PubMed ID: 6764981
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of vaccines against influenza H5.
    Stephenson I; Gust I; Pervikov Y; Kieny MP
    Lancet Infect Dis; 2006 Aug; 6(8):458-60. PubMed ID: 16870521
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative efficacy of inactivated and live attenuated influenza vaccines.
    Monto AS; Ohmit SE; Petrie JG; Johnson E; Truscon R; Teich E; Rotthoff J; Boulton M; Victor JC
    N Engl J Med; 2009 Sep; 361(13):1260-7. PubMed ID: 19776407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A comparative study of live and inactivated influenza vaccines: the organization of the observation and the results of a study of their reactogenicity and immunogenicity].
    Slepushkin AN; Rudenko LG; Kendal AP; Monto AS; Beliaev AL; Burtseva EI; Grigor'eva EP; Obrosova-Serova NP; Ivanova VT; Bragina VE
    Vopr Virusol; 1994; 39(3):129-31. PubMed ID: 8091754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.